Search research articles
Contact Us
Filters
Showing results (81-90 of 170) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer
Divya Gupta, Madhukumar Venkatesh, Hongwei Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 8, 2020
The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins
Sarah L Erickson, Laurie Alston, Kristoff Nieves, et al.
Drug Metabolism Reviews
|
December 13, 2019
Adverse pharmacokinetic interactions between illicit substances and clinical drugs
Kodye L Abbott, Patrick C Flannery, Kristina S Gill, et al.
International Immunopharmacology
|
September 8, 2014
Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation
Wei Dou, Jingjing Zhang, Gaiyan Ren, et al.
Toxicology Letters
|
October 1, 2020
Indole microbial intestinal metabolites expand the repertoire of ligands and agonists of the human pregnane X receptor
Peter Illés, Kristýna Krasulová, Barbora Vyhlídalová, et al.
Clinical Pharmacology and Therapeutics
|
November 13, 2004
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital
Federico Innocenti, Samir D Undevia, Jacqueline Ramírez, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 2025
Unlocking the potential: FKK6 as a microbial mimicry-based therapy for chronic inflammation-associated colorectal cancer in a murine model
Lucia Sládeková, Hao Li, Vera M DesMarais, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
Unlocking the Potential: FKK6 as a Microbial Mimicry-Based Therapy for Chronic Inflammation-Associated Colorectal Cancer in a Murine Model
Lucia Sládeková, Hao Li, Vera M DesMarais, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 25, 2019
Polybrominated Diphenyl Ethers and Gut Microbiome Modulate Metabolic Syndrome-Related Aqueous Metabolites in Mice
David K Scoville, Cindy Yanfei Li, Dongfang Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 5, 2014
Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation
Jingjing Zhang, Lili Ding, Baocan Wang, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 170) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer
Divya Gupta, Madhukumar Venkatesh, Hongwei Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 8, 2020
The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins
Sarah L Erickson, Laurie Alston, Kristoff Nieves, et al.
Drug Metabolism Reviews
|
December 13, 2019
Adverse pharmacokinetic interactions between illicit substances and clinical drugs
Kodye L Abbott, Patrick C Flannery, Kristina S Gill, et al.
International Immunopharmacology
|
September 8, 2014
Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation
Wei Dou, Jingjing Zhang, Gaiyan Ren, et al.
Toxicology Letters
|
October 1, 2020
Indole microbial intestinal metabolites expand the repertoire of ligands and agonists of the human pregnane X receptor
Peter Illés, Kristýna Krasulová, Barbora Vyhlídalová, et al.
Clinical Pharmacology and Therapeutics
|
November 13, 2004
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital
Federico Innocenti, Samir D Undevia, Jacqueline Ramírez, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 2025
Unlocking the potential: FKK6 as a microbial mimicry-based therapy for chronic inflammation-associated colorectal cancer in a murine model
Lucia Sládeková, Hao Li, Vera M DesMarais, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
Unlocking the Potential: FKK6 as a Microbial Mimicry-Based Therapy for Chronic Inflammation-Associated Colorectal Cancer in a Murine Model
Lucia Sládeková, Hao Li, Vera M DesMarais, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 25, 2019
Polybrominated Diphenyl Ethers and Gut Microbiome Modulate Metabolic Syndrome-Related Aqueous Metabolites in Mice
David K Scoville, Cindy Yanfei Li, Dongfang Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 5, 2014
Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation
Jingjing Zhang, Lili Ding, Baocan Wang, et al.
Page
of 17